Objective： This systematic review examined whether radiofrequency ablation （RFA） is a sate treatment modality for benign thyroid nodules （BTNs）. Data Sources： PubMed, Embase, and the Cochrane Library database we...Objective： This systematic review examined whether radiofrequency ablation （RFA） is a sate treatment modality for benign thyroid nodules （BTNs）. Data Sources： PubMed, Embase, and the Cochrane Library database were searched for articles that （a） targeted human beings and （b） had a study population with BTNs that were confirmed by fine-needle aspiration cytology and/or core needle biopsy. Study Selection： Thirty-two studies relating to 3409 patients were included in this systematic review. Results： Based on literatures, no deaths were associated with the procedure, serious complications were rare, and RFA appears to be a sale and well-tolerated treatment modality. However, a broad spectrum of complications offers insights into some undesirable complications, such as track needle seeding and Hornet syndrome. Conclusions： RFA appears to be a safe and well-tolerated treatment modality for BTNs. More research is needed to characterize the complications of RFA for thyroid nodules.展开更多
文摘Objective： This systematic review examined whether radiofrequency ablation （RFA） is a sate treatment modality for benign thyroid nodules （BTNs）. Data Sources： PubMed, Embase, and the Cochrane Library database were searched for articles that （a） targeted human beings and （b） had a study population with BTNs that were confirmed by fine-needle aspiration cytology and/or core needle biopsy. Study Selection： Thirty-two studies relating to 3409 patients were included in this systematic review. Results： Based on literatures, no deaths were associated with the procedure, serious complications were rare, and RFA appears to be a sale and well-tolerated treatment modality. However, a broad spectrum of complications offers insights into some undesirable complications, such as track needle seeding and Hornet syndrome. Conclusions： RFA appears to be a safe and well-tolerated treatment modality for BTNs. More research is needed to characterize the complications of RFA for thyroid nodules.
